Clinical Trial Update: Allogeneic Hematopoietic Cell Transplantation for Severe Systemic Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 1/2 trial evaluating allogeneic hematopoietic cell transplantation for severe systemic sclerosis, with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Systemic Scleroderma, Severe Systemic Sclerosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-06-04